Jacek Mackiewicz

6PUBLICATIONS
44CO-AUTHORS
Molecular targetsInnate immunityPredictive and prognostic markersMedical virologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

|Aug 28, 2025
Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy.

Bernadeta Drymel, Katarzyna Tomela, Łukasz Galus

|Apr 29, 2025
lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients.

Tomasz Kolenda, Piotr Białas, Kacper Guglas

|Dec 17, 2024
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.

Bernadeta Drymel, Katarzyna Tomela, Łukasz Galus

|Feb 05, 2024
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.

Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka

|Nov 30, 2018
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results.

Jacek Mackiewicz, Tomasz Burzykowski, Dariusz Iżycki

Pageof 1

Frequent Collaborators

4 joint publications

Andrzej Mackiewicz

3 joint publications

Katarzyna Tomela

3 joint publications

Bernadeta Pietrzak

3 joint publications

Marcin Schmidt